Tirzepatide: Prospective Research, Potential Properties, and Emerging Domains
Tirzepatide is a synthetic 39 39-amino-acid peptide engineered as a dual agonist at the glucose‐dependent insulinotropic polypeptide receptor (GIPR) and the glucagon‐like peptide‐1 receptor (GLP-1R). Research models have begun to uncover a complex pharmacological profile for this peptide, involving biased signaling, modulation of metabolic and inflammatory pathways, and impacts on various tissues beyond classical incretin…








